In vitro evaluation of photo-crosslinkable chitosan-lactide hydrogels for bone tissue engineering

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 7, 2014, Pages 1393-1406

  Kim, Sungwoo ^a   Kang, Yunqing ^a   Mercado Pagán, Ángel E ^a   Maloney, William J ^a   Yang, Yunzhi ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

Author keywords

BMP 2; C2C12; Chitosan; Lactide; Methacrylic anhydride; Osteoblastic differentiation; Photo crosslinkable hydrogel; W 20 17

Indexed keywords

ALKALINITY; BIOSYNTHESIS; BONE; CELLS; CHITOSAN; CROSSLINKING; CYTOLOGY; DEGRADATION; MINERALOGY; PHOSPHATASES; TISSUE; TISSUE ENGINEERING;

BMP-2; C2C12; CROSS-LINKABLE; LACTIDES; METHACRYLIC ANHYDRIDE; OSTEOBLASTIC DIFFERENTIATION;

HYDROGELS;

ACID ANHYDRIDE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COPOLYMER; LACTIDE; METHACRYLIC ANHYDRIDE; UNCLASSIFIED DRUG; BONE PROSTHESIS; DILACTIDE; DIOXANE DERIVATIVE; GELATINASE A; HYDROGEL; MMP2 PROTEIN, MOUSE;

AMIDATION; ANIMAL CELL; ARTICLE; BIODEGRADATION; BIOMINERALIZATION; BONE MARROW STROMA CELL; BONE TISSUE; CELL DIFFERENTIATION; CELL TYPE; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; ENZYME ACTIVITY; ESTERIFICATION; HARDNESS; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; PHYSICAL CHEMISTRY; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; ULTRAVIOLET RADIATION; YOUNG MODULUS; ANIMAL; BONE MARROW CELL; BONE PROSTHESIS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EVALUATION STUDY; MATERIALS TESTING; METABOLISM; PHARMACOLOGY; PHOTOCHEMISTRY;

ANIMALS; BONE MARROW CELLS; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELL LINE; CHITOSAN; DIOXANES; HYDROGELS; MATERIALS TESTING; MATRIX METALLOPROTEINASE 2; MICE; MYOBLASTS; OSTEOBLASTS; PHOTOCHEMICAL PROCESSES; TISSUE ENGINEERING;

EID: 84899905889     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33118     Document Type: Article

References (42)

1. Uebersax L, Merkle HP, Meinel L. Biopolymer-based growth factor delivery for tissue repair: From natural concepts to engineered systems. Tissue Eng Part B Rev 2009;15:263-289.
2. Vo TN, Kasper FK, Mikos AG. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 2012;64:1292-1309.
3. Jeon O, Powell C, Solorio LD, Krebs MD, Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J Control Release 2011;154:258-266.
4. Pitarresi G, Casadei MA, Mandracchia D, Paolicelli P, Palumbo FS, Giammona G. Photocrosslinking of dextran and polyaspartamide derivatives: A combination suitable for colon-specific drug delivery. J Control Release 2007;119:328-338.
5. Leach JB, Schmidt CE. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials 2005;26:125-135.
6. Billiet T, Vandenhaute M, Schelfhout J, Vlierberghe SV, Dubruel P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 2012;33: 6020-6041.
7. Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Seol YJ, Chung CP, Lee SJ. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 2002;78: 187-197.
8. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003;9 (Suppl 1):S5-S15.
9. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, Yang Y. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acidcomposite biomaterial. Biomaterials 2009;30:4743-4751.
10. Lü S, Liu M, Ni B. An injectable oxidized carboxymethyl cellulose/N-succinyl-chitosan hydrogel system for protein delivery. Chem Eng J 2010;160:779-787.
11. Liu Y, Tian F, Hu KA. Synthesis and characterization of a brushlike copolymer of polylactide grafted onto chitosan. Carbohydr Res 2004;339:845-851.
12. Wu Y, Zheng Y, Yang W, Wang C, Hu J, Fu S. Synthesis and characterization of a novel amphiphilic chitosan-polylactide graft copolymer. Carbohydr Polym 2005;59:165-171.
13. Bhattarai N, Ramay HR, Chou SH, Zhang M. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomed 2006;1:181-187.
14. Ivirico JLE, Salmeron-Sanchez M, Ribelles JG, Pradas MM. Poly(Llactide) networks with tailored water sorption. Colloid Polym Sci 2009;287:671-681.
15. Yu LM, Kazazian K, Shoichet MS. Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications. J Biomed Mater Res A 2007;82:243-255.
16. Radhakumary C, Nair PD, Mathew S, Nair CP. Biopolymer composite of chitosan and methyl methacrylate for medical applications. Trends Biomater Artif Organs 2005;18:117-124.
17. An J, Yuan X, Luo Q, Wang D. Preparation of chitosan-graft- (methylmethacrylate)/Ag nanocomposite with antimicrobial activity. Polym Int 2010;59:62-70.
18. Hong Y, Song H, Gong Y, Mao Z, Gao C, Shen J. Covalently crosslinked chitosan hydrogel: Properties of in vitro degradation and chondrocyte encapsulation. Acta Biomater 2007;3:23-31.
19. Porstmann B, Jung K, Schmechta H, Evers U, Pergande M, Porstmann T, Kramm HJ, Krause H. Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem 1989; 22:349-355.
20. Kowapradit J, Opanasopit P, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W. Methylated N-(4-N, N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2). AAPS Pharm Sci Technol 2008;9:1143-1152.
21. Calori GM, Donati D, Di Bella C, Tagliabue L. Bone morphogenetic proteins and tissue engineering: Future directions. Injury 2009;40: S67-S76.
22. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 2011;11:471-491.
23. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-547.
24. Lin CC, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Adv Drug Deliv Rev 2006;58:1379-1408.
25. Al-Kahtani Ahmed A, Bhojya Naik HS, Sherigara BS. Synthesis and characterization of chitosan-based pH-sensitive semiinterpenetrating network microspheres for controlled release of diclofenac sodium. Carbohydr Res 2009;344:699-706.
26. Guo BL, Gao QY. Preparation and properties of a pH/temperatureresponsive carboxymethyl chitosan/poly(N-isopropylacrylamide) semi-IPN hydrogel for oral delivery of drugs. Carbohydr Res 2007; 342:2416-2422.
27. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48:139-157.
28. Stokke BT, Varum KM, Holme HK, Hjerde RJN, Smidsrod O. Sequence specificities for lysozyme depolymerization of partially N-acetylated chitosans. Can J Chem 1995;73:1972-1981.
29. Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 2005;26:5872-5878.
30. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992;130:1318-1324.
31. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008;29:3245-3252.
32. Kim S, Tsao H, Kang Y, Young DA, Sen M, Wenke JC, Yang Y. In vitro evaluation of an injectable chitosan gel for sustained local delivery of BMP-2 for osteoblastic differentiation. J Biomed Mater Res B Appl Biomater 2011;99:380-390.
33. Nguyen AH, Kim S, Maloney WJ, Wenke JC, Yang Y. Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro. Antimicrob Agents Chemother 2012;56: 3776-3784.
34. Liu R, Ginn SL, Lek M, North KN, Alexander IE, Little DG, Schindeler A. Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a. BMC Musculoskelet Disord 2009;10:1-12.
35. Bramono DS, Murali S, Rai B, Ling L, Poh WT, Lim ZX, Stein GS, Nurcombe V, van Wijnen AJ, Cool SM. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 2012;50:954-964.
36. Jeong BC, Lee YS, Park YY, Bae IH, Kim DK, Koo SH, Choi HR, Kim SH, Franceschi RT, Koh JT, Choi HS. The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J Biol Chem 2009;284:14211-14218.
37. Schindeler A, Liu R, Little DG. The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. Differentiation 2009;77:12-18.
38. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766.
39. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113: 681-687.
40. Bhakta G, Rai B, Lim ZX, Hui JH, Stein GS, van Wijnen AJ, Nurcombe V, Prestwich GD, Cool SM. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 2012;33:6113-6122.
41. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am 2003;85:19-28.
42. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Cells Tissues Organs 2004;176:109-119.